The estimated Net Worth of Matthew S. Holt is at least $131 Million dollars as of 12 February 2015. Mr. Holt owns over 1,070,166 units of Avantor stock worth over $130,779,505 and over the last 10 years he sold AVTR stock worth over $0. In addition, he makes $0 as Director at Avantor.
Matthew has made over 1 trades of the Avantor stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 1,070,166 units of AVTR stock worth $12,841,992 on 12 February 2015.
The largest trade he's ever made was buying 1,070,166 units of Avantor stock on 12 February 2015 worth over $12,841,992. On average, Matthew trades about 97,288 units every 0 days since 2015. As of 12 February 2015 he still owns at least 4,859,885 units of Avantor stock.
You can see the complete history of Mr. Holt stock trades at the bottom of the page.
Matthew S. Holt is Director of the Company. Mr. Holt has served on our Board since 2010 and is currently the Chair of the Compensation and Human Resources Committee. Mr. Holt is a Managing Director of New Mountain Capital, LLC, a private equity investment firm based in New York, New York. He serves as the Deputy Head of Private Equity at New Mountain and focuses on growth buyouts across a range of industries including healthcare products, health technology, materials and infrastructure. He previously worked in the Mergers and Acquisitions Group at Lehman Brothers, a financial services firm, from 1999 to 2001. He currently serves as Lead Director or Chairman of CIOX Health, Cytel, emids, Ontario Systems, Revint Solutions, Signify Health, W20 and Zep, Inc. He also serves as a director of Aceto, Topix Pharmaceuticals, Gelest and TRC Companies. Mr. Holt has previously served as Lead Director of Bellerophon Therapeutics, Inc., Convey Health Solutions, Inc., Equian LLC, Ikaria, Inc., Nusil Technology LLC, and Director of MailSouth. Mr. Holt earned an A.B. in English and American Literature and Language from Harvard College.
Matthew Holt is 43, he's been the Director of Avantor since 2010. There are 28 older and 3 younger executives at Avantor. The oldest executive at Avantor Inc. is Rajiv Gupta, 74, who is the Chairman of the Board.
Matthew's mailing address filed with the SEC is C/O SIGNIFY HEALTH, INC., 4055 VALLEY VIEW LN, SUITE 700, DALLAS, TX, 75244.
Over the last 6 years, insiders at Avantor have traded over $3,149,576,044 worth of Avantor stock and bought 27,800 units worth $584,024 . The most active insiders traders include Mountain Investments Iii, L..., Jo Natauri und Sachs & Co. Llc Stone Bridg.... On average, Avantor executives and independent directors trade stock every 21 days with the average trade being worth of $48,107,115. The most recent stock trade was executed by Steven W Eck on 5 September 2024, trading 3,525 units of AVTR stock currently worth $88,337.
based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. our electronics solutions are used in the manufacturing of semiconductors. for additional information please visit www.avantormaterials.com
Avantor executives and other stock owners filed with the SEC include: